Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-04

Clinical Trial Update: Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the effectiveness and safety of a fixed-dose combination of Nebivolol and Amlodipine against each monotherapy in hypertensive patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Nebivolol (Nebivolol)

Snippet

Sponsor: Menarini International Operations Luxembourg SA | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2025-02-04